NEW YORK (Reuters Health) – Three years after ST-segment elevation myocardial infarction (STEMI), sirolimus-eluting stents still provide better protection against major adverse cardiovascular events compared to bare metal…
NEW YORK (Reuters Health) – Patients report higher quality of life with continuous intraperitoneal versus subcutaneous insulin, Dutch investigators have found. The researchers had previously reported that continuous…
NEW YORK (Reuters Health) – Tenofovir nephrotoxicity can’t always be fully reversed in HIV-infected men, according to a new study. Up to 2% of patients have adverse renal…
NEW YORK (Reuters Health) – Ethosuximide and valproic acid are more effective than lamotrigine for treating childhood absence epilepsy, the most common pediatric epilepsy syndrome, according to a…
NEW YORK (Reuters Health) – Asymptomatic patients with a low ankle brachial index don’t seem to get cardiovascular protection from aspirin, randomized trial results suggest. The subjects came…
NEW YORK (Reuters Health) – In treating social anxiety disorder, phenelzine combined with cognitive behavioral group therapy achieves a higher response rates than either treatment alone or placebo,…
NEW YORK (Reuters Health) – Montelukast (Singulair), a leukotriene receptor antagonist, can help prevent recurrent wheezing episodes after respiratory syncytial virus (RSV) bronchiolitis, new research shows. From earlier…
NEW YORK (Reuters Health) – Belatacept-based immunosuppression after kidney transplantation allows for better renal function compared to cyclosporine, with similar graft and patient survival, phase III trial results…
NEW YORK (Reuters Health) – Intensive insulin therapy in type 1 diabetics reduces their risks of neuropathy and retinopathy over the long-term, according to two papers published online…
NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…